Infection Control Market: Market Size & Forecast 2026

The infection control market spans sterilizers, disinfectants, protective apparel, sterilization services, and infection surveillance systems used primarily by hospitals, clinics, ambulatory surgical centers, and pharmaceutical manufacturing facilities. With an estimated market size of approximately $71.66 billion in 2025, the sector is experiencing steady expansion as healthcare providers invest in infection prevention infrastructure. Regional analyses consistently identify North America as the dominant market, supported by advanced healthcare infrastructure, stringent regulatory frameworks, and high awareness of healthcare-associated infections.

• •Market valued at approximately $71.66 billion in 2025, with projected CAGR of ~6.3%
• •North America holds the largest market share driven by strict regulations and mature healthcare infrastructure
• •Hospitals and clinics constitute the largest end-user segment by revenue

The persistent threat of healthcare-associated infections, which affect millions of patients globally each year, remains the primary catalyst for market expansion. Rising prevalence of chronic diseases, an aging demographic profile, and the growing burden of antibiotic-resistant organisms such as MRSA and multidrug-resistant Gram-negative bacteria continue to pressure healthcare systems to strengthen infection prevention measures. The COVID-19 pandemic further accelerated investments in sterilization, personal protective equipment, and infection surveillance systems, with many of those spending commitments sustaining forward momentum.

• •Growing prevalence of hospital-acquired infections and antimicrobial resistance fuels demand for sterilization and disinfection products
• •Aging global population and rising prevalence of chronic diseases increase exposure risk and healthcare utilization
• •Stringent regulatory requirements from agencies such as the FDA, CDC, and WHO mandate infection control compliance

The market is typically segmented by product type, including disinfectants and sterilizers, protective apparel, and infection surveillance systems, as well as by end user, where hospitals represent the largest segment. Geographically, North America leads in market value due to advanced healthcare infrastructure, well-established regulatory frameworks, and substantial healthcare spending. Europe follows as the second-largest market, while the Asia-Pacific region is anticipated to record the fastest growth, propelled by expanding healthcare access, rising medical tourism, and growing awareness of infection prevention standards.

• •Hospitals and clinics dominate end-user demand, supported by high patient volumes and regulatory compliance requirements
• •Asia-Pacific is projected as the fastest-growing region due to healthcare infrastructure expansion and rising infection prevention awareness
• •Product segmentation includes disinfectants/sterilants, PPE, and infection monitoring/epidemiology solutions

What are the recent trends and outlook?

The market is being reshaped by the integration of artificial intelligence and digital technologies into infection surveillance, enabling real-time monitoring, predictive analytics, and automated outbreak detection. Sustainability and environmental considerations are driving demand for greener disinfectants and reusable sterilization methods. Single-use disposable products continue to hold significant market share, though cost pressures and environmental regulations are encouraging a shift toward more sustainable alternatives. Looking ahead, the combination of technology-driven surveillance, evolving regulatory standards, and ongoing public health preparedness investments is expected to sustain the market's growth trajectory through the end of the decade.

• •AI-powered infection surveillance and digital monitoring systems are emerging as transformative tools for hospital infection prevention
• •Demand for eco-friendly and sustainable disinfectant formulations is increasing due to environmental regulations
• •Single-use disposable infection control products remain dominant, though reusable alternatives gain traction in cost-sensitive markets